Your browser doesn't support javascript.
loading
Short Communication: Therapeutic Immunization Benefits Mucosal-Associated Invariant T Cell Recovery in Contrast to Interleukin-2, Granulocyte-Macrophage Colony-Stimulating Factor, and Recombinant Human Growth Hormone Addition in HIV-1+ Treated Patients: Individual Case Reports from Phase I Trial.
Cocker, Alexander T H; Greathead, Louise; Herasimtschuk, Anna A; Mandalia, Sundhiya; Kelleher, Peter; Imami, Nesrina.
Affiliation
  • Cocker ATH; Department of Medicine, Imperial College London, London, United Kingdom.
  • Greathead L; Department of Medicine, Imperial College London, London, United Kingdom.
  • Herasimtschuk AA; Department of Medicine, Imperial College London, London, United Kingdom.
  • Mandalia S; Department of Medicine, Imperial College London, London, United Kingdom.
  • Kelleher P; Department of Medicine, Imperial College London, London, United Kingdom.
  • Imami N; Department of Medicine, Imperial College London, London, United Kingdom.
AIDS Res Hum Retroviruses ; 35(3): 306-309, 2019 03.
Article in En | MEDLINE | ID: mdl-30600702
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Granulocyte-Macrophage Colony-Stimulating Factor / HIV-1 / HIV Seropositivity / Immunization / Interleukin-2 / AIDS Vaccines / Human Growth Hormone / Anti-Retroviral Agents / Mucosal-Associated Invariant T Cells Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: AIDS Res Hum Retroviruses Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2019 Document type: Article Affiliation country: United kingdom Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Granulocyte-Macrophage Colony-Stimulating Factor / HIV-1 / HIV Seropositivity / Immunization / Interleukin-2 / AIDS Vaccines / Human Growth Hormone / Anti-Retroviral Agents / Mucosal-Associated Invariant T Cells Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: AIDS Res Hum Retroviruses Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2019 Document type: Article Affiliation country: United kingdom Country of publication: United States